Preconditioning With a Combination of Thiotepa, Cyclophosphamide, and Busulfan for Allogeneic Hematopoietic Stem Cell Transplantation in the Treatment of NK/T-Cell Lymphoma

NCT07276737 · clinicaltrials.gov ↗

PHASE2

Phase

NOT_YET_RECRUITING

Status

37

Enrollment

OTHER

Sponsor class

Conditions

NK T-Cell Lymphoma

Interventions

DRUG: Thiotepa

Sponsor

Shanghai General Hospital, Shanghai Jiao Tong University School of Medicine